期刊
TRANSLATIONAL RESEARCH
卷 241, 期 -, 页码 41-51出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2021.09.002
关键词
-
资金
- National Institute on Aging/NIH [R01AG067457]
Neurologic symptoms caused by COVID-19 can vary in severity, with some being mild while others can be life-threatening. These symptoms often persist after the acute phase of the illness, posing challenges for diagnosis and treatment.
The worldwide pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected an estimated 200 million people with over 4 million deaths. Although COVID-19, the disease caused by the SARS-CoV-2 virus, is primarily a respiratory disease, an increasing number of neurologic symptoms have been reported. Some of these symptoms, such as loss of smell or taste, are mild and non-life threatening, while others, such as stroke or seizure, are more critical. Many of these symptoms remain long after the acute illness has passed, a phenomenon known as long COVID or postacute sequelae of SARS-CoV-2 infection (PASC). Neurological symptoms can be difficult to study due to the complexity of the central and peripheral nervous system. These neurologic symptoms can be difficult to identify and quantitate. This narrative review will describe approaches for assessing neurologic manifestations of COVID-19, with examples of the data they provide, as well as some directions for future research to aid in understanding the pathophysiology of COVID-19-related neurological implications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据